CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: NEONATAL INTENSIVE CARE MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Warmers
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Incubators
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.3.4 Incubators Neonatal Intensive Care Market by Type
4.3.4.1 Hybrid Incubator Market size and forecast, by region
4.3.4.2 Normal Incubator Market size and forecast, by region
4.3.4.3 Transport Incubator Market size and forecast, by region
4.4 Monitoring Devices
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Respiratory Devices
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Phototherapy Equipment
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
4.7 Others
4.7.1 Key market trends, growth factors and opportunities
4.7.2 Market size and forecast, by region
4.7.3 Market analysis by country
CHAPTER 5: NEONATAL INTENSIVE CARE MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Neonatal Hypothermia & Low Birth Weight
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Jaundice
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Others
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: NEONATAL INTENSIVE CARE MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospitals
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Maternity Hospitals
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Neonatal & Pediatric Hospital
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: NEONATAL INTENSIVE CARE MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product
7.2.2.1 North America Incubators Neonatal Intensive Care Market by Type
7.2.3 North America Market size and forecast, by Application
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Product
7.2.5.1.2 Market size and forecast, by Application
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Product
7.2.5.2.2 Market size and forecast, by Application
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Product
7.2.5.3.2 Market size and forecast, by Application
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product
7.3.2.1 Europe Incubators Neonatal Intensive Care Market by Type
7.3.3 Europe Market size and forecast, by Application
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Product
7.3.5.1.2 Market size and forecast, by Application
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Product
7.3.5.2.2 Market size and forecast, by Application
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Product
7.3.5.3.2 Market size and forecast, by Application
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Product
7.3.5.4.2 Market size and forecast, by Application
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Product
7.3.5.5.2 Market size and forecast, by Application
7.3.5.5.3 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Product
7.3.5.6.2 Market size and forecast, by Application
7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product
7.4.2.1 Asia-Pacific Incubators Neonatal Intensive Care Market by Type
7.4.3 Asia-Pacific Market size and forecast, by Application
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Product
7.4.5.1.2 Market size and forecast, by Application
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 Japan
7.4.5.2.1 Market size and forecast, by Product
7.4.5.2.2 Market size and forecast, by Application
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Product
7.4.5.3.2 Market size and forecast, by Application
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 Australia
7.4.5.4.1 Market size and forecast, by Product
7.4.5.4.2 Market size and forecast, by Application
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Product
7.4.5.5.2 Market size and forecast, by Application
7.4.5.5.3 Market size and forecast, by End User
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Market size and forecast, by Product
7.4.5.6.2 Market size and forecast, by Application
7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product
7.5.2.1 LAMEA Incubators Neonatal Intensive Care Market by Type
7.5.3 LAMEA Market size and forecast, by Application
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Product
7.5.5.1.2 Market size and forecast, by Application
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Product
7.5.5.2.2 Market size and forecast, by Application
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Product
7.5.5.3.2 Market size and forecast, by Application
7.5.5.3.3 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Product
7.5.5.4.2 Market size and forecast, by Application
7.5.5.4.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Drägerwerk AG & Co. KGaA
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 GE Company
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Masimo Corporation
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 3M Company
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Phoenix Medical Systems Pvt Ltd.
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Medtronic PLC
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Koninklijke Philips N.V
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Fanem Medical Devices
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Atom Medica
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Mediprema Group
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
9.11 Siemens Healthcare GmbH
9.11.1 Company overview
9.11.2 Company snapshot
9.11.3 Operating business segments
9.11.4 Product portfolio
9.11.5 Business performance
9.11.6 Key strategic moves and developments
9.12 Terumo Corporation
9.12.1 Company overview
9.12.2 Company snapshot
9.12.3 Operating business segments
9.12.4 Product portfolio
9.12.5 Business performance
9.12.6 Key strategic moves and developments
9.13 Medicor Elektronika
9.13.1 Company overview
9.13.2 Company snapshot
9.13.3 Operating business segments
9.13.4 Product portfolio
9.13.5 Business performance
9.13.6 Key strategic moves and developments
9.14 Ningbo David Medical Device Co., Ltd.
9.14.1 Company overview
9.14.2 Company snapshot
9.14.3 Operating business segments
9.14.4 Product portfolio
9.14.5 Business performance
9.14.6 Key strategic moves and developments
9.15 Zhengzhou Dison Instrument And Meter Co., Ltd
9.15.1 Company overview
9.15.2 Company snapshot
9.15.3 Operating business segments
9.15.4 Product portfolio
9.15.5 Business performance
9.15.6 Key strategic moves and developments
9.16 AngioDynamics
9.16.1 Company overview
9.16.2 Company snapshot
9.16.3 Operating business segments
9.16.4 Product portfolio
9.16.5 Business performance
9.16.6 Key strategic moves and developments
9.17 Vygon (UK) Ltd
9.17.1 Company overview
9.17.2 Company snapshot
9.17.3 Operating business segments
9.17.4 Product portfolio
9.17.5 Business performance
9.17.6 Key strategic moves and developments
TABLE 1. GLOBAL NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 2. NEONATAL INTENSIVE CARE MARKET SIZE, FOR WARMERS, BY REGION, 2021-2031 ($MILLION)
TABLE 3. NEONATAL INTENSIVE CARE MARKET FOR WARMERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. NEONATAL INTENSIVE CARE MARKET SIZE, FOR INCUBATORS, BY REGION, 2021-2031 ($MILLION)
TABLE 5. NEONATAL INTENSIVE CARE MARKET FOR INCUBATORS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 6. GLOBAL INCUBATORS NEONATAL INTENSIVE CARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 7. NEONATAL INTENSIVE CARE MARKET, FOR HYBRID INCUBATOR, BY REGION, 2021-2031 ($MILLION)
TABLE 8. NEONATAL INTENSIVE CARE MARKET, FOR NORMAL INCUBATOR, BY REGION, 2021-2031 ($MILLION)
TABLE 9. NEONATAL INTENSIVE CARE MARKET, FOR TRANSPORT INCUBATOR, BY REGION, 2021-2031 ($MILLION)
TABLE 10. NEONATAL INTENSIVE CARE MARKET SIZE, FOR MONITORING DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 11. NEONATAL INTENSIVE CARE MARKET FOR MONITORING DEVICES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 12. NEONATAL INTENSIVE CARE MARKET SIZE, FOR RESPIRATORY DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 13. NEONATAL INTENSIVE CARE MARKET FOR RESPIRATORY DEVICES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 14. NEONATAL INTENSIVE CARE MARKET SIZE, FOR PHOTOTHERAPY EQUIPMENT, BY REGION, 2021-2031 ($MILLION)
TABLE 15. NEONATAL INTENSIVE CARE MARKET FOR PHOTOTHERAPY EQUIPMENT, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 16. NEONATAL INTENSIVE CARE MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 17. NEONATAL INTENSIVE CARE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 18. GLOBAL NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 19. NEONATAL INTENSIVE CARE MARKET SIZE, FOR NEONATAL HYPOTHERMIA & LOW BIRTH WEIGHT, BY REGION, 2021-2031 ($MILLION)
TABLE 20. NEONATAL INTENSIVE CARE MARKET FOR NEONATAL HYPOTHERMIA & LOW BIRTH WEIGHT, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 21. NEONATAL INTENSIVE CARE MARKET SIZE, FOR JAUNDICE, BY REGION, 2021-2031 ($MILLION)
TABLE 22. NEONATAL INTENSIVE CARE MARKET FOR JAUNDICE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 23. NEONATAL INTENSIVE CARE MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 24. NEONATAL INTENSIVE CARE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 25. GLOBAL NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 26. NEONATAL INTENSIVE CARE MARKET SIZE, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
TABLE 27. NEONATAL INTENSIVE CARE MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 28. NEONATAL INTENSIVE CARE MARKET SIZE, FOR MATERNITY HOSPITALS, BY REGION, 2021-2031 ($MILLION)
TABLE 29. NEONATAL INTENSIVE CARE MARKET FOR MATERNITY HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 30. NEONATAL INTENSIVE CARE MARKET SIZE, FOR NEONATAL & PEDIATRIC HOSPITAL, BY REGION, 2021-2031 ($MILLION)
TABLE 31. NEONATAL INTENSIVE CARE MARKET FOR NEONATAL & PEDIATRIC HOSPITAL, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 32. NEONATAL INTENSIVE CARE MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 33. NORTH AMERICA NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 34. NORTH AMERICA INCUBATORS NEONATAL INTENSIVE CARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 35. NORTH AMERICA NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 36. NORTH AMERICA NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 37. NORTH AMERICA NEONATAL INTENSIVE CARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 38. U.S. NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 39. U.S. NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 40. U.S. NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 41. CANADA NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 42. CANADA NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 43. CANADA NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 44. MEXICO NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 45. MEXICO NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 46. MEXICO NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 47. EUROPE NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 48. EUROPE INCUBATORS NEONATAL INTENSIVE CARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 49. EUROPE NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 50. EUROPE NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 51. EUROPE NEONATAL INTENSIVE CARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 52. GERMANY NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 53. GERMANY NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 54. GERMANY NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 55. FRANCE NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 56. FRANCE NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 57. FRANCE NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 58. UK NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 59. UK NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 60. UK NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 61. ITALY NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 62. ITALY NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 63. ITALY NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 64. SPAIN NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 65. SPAIN NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 66. SPAIN NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 67. REST OF EUROPE NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 68. REST OF EUROPE NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 69. REST OF EUROPE NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 70. ASIA-PACIFIC NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 71. ASIA-PACIFIC INCUBATORS NEONATAL INTENSIVE CARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 72. ASIA-PACIFIC NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 73. ASIA-PACIFIC NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 74. ASIA-PACIFIC NEONATAL INTENSIVE CARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 75. CHINA NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 76. CHINA NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 77. CHINA NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 78. JAPAN NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 79. JAPAN NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 80. JAPAN NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 81. INDIA NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 82. INDIA NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 83. INDIA NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 84. AUSTRALIA NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 85. AUSTRALIA NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 86. AUSTRALIA NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 87. SOUTH KOREA NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 88. SOUTH KOREA NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 89. SOUTH KOREA NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 90. REST OF ASIA-PACIFIC NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 91. REST OF ASIA-PACIFIC NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 92. REST OF ASIA-PACIFIC NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 93. LAMEA NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 94. LAMEA INCUBATORS NEONATAL INTENSIVE CARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 95. LAMEA NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 96. LAMEA NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 97. LAMEA NEONATAL INTENSIVE CARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 98. BRAZIL NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 99. BRAZIL NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 100. BRAZIL NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 101. SAUDI ARABIA NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 102. SAUDI ARABIA NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 103. SAUDI ARABIA NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 104. SOUTH AFRICA NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 105. SOUTH AFRICA NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 106. SOUTH AFRICA NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 107. REST OF LAMEA NEONATAL INTENSIVE CARE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 108. REST OF LAMEA NEONATAL INTENSIVE CARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 109. REST OF LAMEA NEONATAL INTENSIVE CARE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 110.DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT
TABLE 111.DRÄGERWERK AG & CO. KGAA: OPERATING SEGMENTS
TABLE 112.DRÄGERWERK AG & CO. KGAA: PRODUCT PORTFOLIO
TABLE 113.DRÄGERWERK AG & CO. KGAA: NET SALES,
TABLE 114.DRÄGERWERK AG & CO. KGAA: KEY STRATERGIES
TABLE 115.GE COMPANY: COMPANY SNAPSHOT
TABLE 116.GE COMPANY: OPERATING SEGMENTS
TABLE 117.GE COMPANY: PRODUCT PORTFOLIO
TABLE 118.GE COMPANY: NET SALES,
TABLE 119.GE COMPANY: KEY STRATERGIES
TABLE 120.MASIMO CORPORATION: COMPANY SNAPSHOT
TABLE 121.MASIMO CORPORATION: OPERATING SEGMENTS
TABLE 122.MASIMO CORPORATION: PRODUCT PORTFOLIO
TABLE 123.MASIMO CORPORATION: NET SALES,
TABLE 124.MASIMO CORPORATION: KEY STRATERGIES
TABLE 125.3M COMPANY: COMPANY SNAPSHOT
TABLE 126.3M COMPANY: OPERATING SEGMENTS
TABLE 127.3M COMPANY: PRODUCT PORTFOLIO
TABLE 128.3M COMPANY: NET SALES,
TABLE 129.3M COMPANY: KEY STRATERGIES
TABLE 130.PHOENIX MEDICAL SYSTEMS PVT LTD.: COMPANY SNAPSHOT
TABLE 131.PHOENIX MEDICAL SYSTEMS PVT LTD.: OPERATING SEGMENTS
TABLE 132.PHOENIX MEDICAL SYSTEMS PVT LTD.: PRODUCT PORTFOLIO
TABLE 133.PHOENIX MEDICAL SYSTEMS PVT LTD.: NET SALES,
TABLE 134.PHOENIX MEDICAL SYSTEMS PVT LTD.: KEY STRATERGIES
TABLE 135.MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 136.MEDTRONIC PLC: OPERATING SEGMENTS
TABLE 137.MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 138.MEDTRONIC PLC: NET SALES,
TABLE 139.MEDTRONIC PLC: KEY STRATERGIES
TABLE 140.KONINKLIJKE PHILIPS N.V: COMPANY SNAPSHOT
TABLE 141.KONINKLIJKE PHILIPS N.V: OPERATING SEGMENTS
TABLE 142.KONINKLIJKE PHILIPS N.V: PRODUCT PORTFOLIO
TABLE 143.KONINKLIJKE PHILIPS N.V: NET SALES,
TABLE 144.KONINKLIJKE PHILIPS N.V: KEY STRATERGIES
TABLE 145.FANEM MEDICAL DEVICES: COMPANY SNAPSHOT
TABLE 146.FANEM MEDICAL DEVICES: OPERATING SEGMENTS
TABLE 147.FANEM MEDICAL DEVICES: PRODUCT PORTFOLIO
TABLE 148.FANEM MEDICAL DEVICES: NET SALES,
TABLE 149.FANEM MEDICAL DEVICES: KEY STRATERGIES
TABLE 150.ATOM MEDICA: COMPANY SNAPSHOT
TABLE 151.ATOM MEDICA: OPERATING SEGMENTS
TABLE 152.ATOM MEDICA: PRODUCT PORTFOLIO
TABLE 153.ATOM MEDICA: NET SALES,
TABLE 154.ATOM MEDICA: KEY STRATERGIES
TABLE 155.MEDIPREMA GROUP: COMPANY SNAPSHOT
TABLE 156.MEDIPREMA GROUP: OPERATING SEGMENTS
TABLE 157.MEDIPREMA GROUP: PRODUCT PORTFOLIO
TABLE 158.MEDIPREMA GROUP: NET SALES,
TABLE 159.MEDIPREMA GROUP: KEY STRATERGIES
TABLE 160.SIEMENS HEALTHCARE GMBH: COMPANY SNAPSHOT
TABLE 161.SIEMENS HEALTHCARE GMBH: OPERATING SEGMENTS
TABLE 162.SIEMENS HEALTHCARE GMBH: PRODUCT PORTFOLIO
TABLE 163.SIEMENS HEALTHCARE GMBH: NET SALES,
TABLE 164.SIEMENS HEALTHCARE GMBH: KEY STRATERGIES
TABLE 165.TERUMO CORPORATION: COMPANY SNAPSHOT
TABLE 166.TERUMO CORPORATION: OPERATING SEGMENTS
TABLE 167.TERUMO CORPORATION: PRODUCT PORTFOLIO
TABLE 168.TERUMO CORPORATION: NET SALES,
TABLE 169.TERUMO CORPORATION: KEY STRATERGIES
TABLE 170.MEDICOR ELEKTRONIKA: COMPANY SNAPSHOT
TABLE 171.MEDICOR ELEKTRONIKA: OPERATING SEGMENTS
TABLE 172.MEDICOR ELEKTRONIKA: PRODUCT PORTFOLIO
TABLE 173.MEDICOR ELEKTRONIKA: NET SALES,
TABLE 174.MEDICOR ELEKTRONIKA: KEY STRATERGIES
TABLE 175.NINGBO DAVID MEDICAL DEVICE CO., LTD.: COMPANY SNAPSHOT
TABLE 176.NINGBO DAVID MEDICAL DEVICE CO., LTD.: OPERATING SEGMENTS
TABLE 177.NINGBO DAVID MEDICAL DEVICE CO., LTD.: PRODUCT PORTFOLIO
TABLE 178.NINGBO DAVID MEDICAL DEVICE CO., LTD.: NET SALES,
TABLE 179.NINGBO DAVID MEDICAL DEVICE CO., LTD.: KEY STRATERGIES
TABLE 180.ZHENGZHOU DISON INSTRUMENT AND METER CO., LTD: COMPANY SNAPSHOT
TABLE 181.ZHENGZHOU DISON INSTRUMENT AND METER CO., LTD: OPERATING SEGMENTS
TABLE 182.ZHENGZHOU DISON INSTRUMENT AND METER CO., LTD: PRODUCT PORTFOLIO
TABLE 183.ZHENGZHOU DISON INSTRUMENT AND METER CO., LTD: NET SALES,
TABLE 184.ZHENGZHOU DISON INSTRUMENT AND METER CO., LTD: KEY STRATERGIES
TABLE 185.ANGIODYNAMICS: COMPANY SNAPSHOT
TABLE 186.ANGIODYNAMICS: OPERATING SEGMENTS
TABLE 187.ANGIODYNAMICS: PRODUCT PORTFOLIO
TABLE 188.ANGIODYNAMICS: NET SALES,
TABLE 189.ANGIODYNAMICS: KEY STRATERGIES
TABLE 190.VYGON (UK) LTD: COMPANY SNAPSHOT
TABLE 191.VYGON (UK) LTD: OPERATING SEGMENTS
TABLE 192.VYGON (UK) LTD: PRODUCT PORTFOLIO
TABLE 193.VYGON (UK) LTD: NET SALES,
TABLE 194.VYGON (UK) LTD: KEY STRATERGIES
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/